The importance of fecal calprotectin in the diagnostics and treatment of inflammatory bowel diseases
Review articleGastroent Hepatol 2015; 69(1): 43–49. doi:doi: 10.14735/amgh201543
SummaryLiteraturepdf Juraj Letkovský, Tibor HlavatýBiosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study
Original articleGastroent Hepatol 2016; 70(1): 27–36. doi:10.14735/amgh201627
SummaryLiteraturepdf Tibor Hlavatý, Anna Krajčovičová, Igor Šturdík, Juraj Letkovský, Tomáš Koller, Jozef Tóth, Martin Huorka